Nationwide, health systems are increasingly turning to nurse scientists to close evidence gaps, answer pressing clinical questions and translate ...

Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific ADC ...

(NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Keith Gottesdiener, M.D., to its ...

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that Andreea Creanga, MD, PhD, a distinguished and internationally recognized leader in maternal and perinatal ...

A large, long-term study led by an Albert Einstein College of Medicine researcher has found that the introduction of the ...

In a comment published in Nature Climate Change, Mark Bradford, the E.H. Harriman Professor of Soils and Ecosystem Ecology, ...

Florida State University's Stoops Center for Communities, Families, and Children (Stoops CFC), housed in the College of Social Work, was awarded a $2 ...

From artificial intelligence to insurance hurdles straining patient care, nine physicians joined Becker’s to discuss the biggest disruptor affecting physicians right now. Question: Which new disruptor ...

As previously reported, Deborah Parker, professor of Italian emerita, formally received the 2025 Art in Literature: The Mary ...

IMPACT-HTN, a novel initiative to modernize hypertension care, has been launched by Idorsia at Stanford Hypertension Center and Duke Heart Center.

Direct-to-consumer devices promising pain relief are flooding the market. Is there enough evidence to recommend these devices to patients with chronic pain?